BALTIMORE — Maryland Medicare patients are paying 4.4 times more for brand-name diabetes medications than patients in Australia, according to a new report prepared by the staff of the House Committee on Oversight and Reform.
They also found that on average, uninsured patients buying a popular insulin, Novolog Flexpen, will pay $650 for a month's supply compared to $28 in Australia.
Diabetics need insulin to survive, but for some people, they just can't afford it at today's prices.
Dr. Sherita Hill Golden, Executive Vice-Chair for the Department of Medicine at the Johns Hopkins University School of Medicine, has seen patients ration their supply to make it last longer or stop using their medications.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
No kidding. This has been known since prescribing drugs was implemented. The US keeps the drug companies in business. The ONLY president who has made this an issue is President Trump. It's another one of the many ways the US is treated unfairly. We pay dearly while other countries demand low costs from the drug companies. But you know stupid useless brainless democrat voters are worried about Confederate statues and made up racism.
ReplyDeleteTo ALL you local Azar supporters I doubt you'll hear anything from him on this ongoing issue. He's like the rest with his big pharma influences and now government position he's raping the general public like the rest of Washington's cronies. Nothing but legalized theft and extortion
ReplyDeleteAre you being forced to go to him? Answer is NO. YOU made the choice.
DeleteWhere is the outrage from our State and Federal legislators?
ReplyDeleteSecondly, how many of them own stock in those very drug companies?
Husband is an uninsured diabetic. Sends for his insulin from Canada. Is a third of the US price.
ReplyDelete